(Q46797792)

25 December 2017

title

Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study (English)

1 reference

25 December 2017

0 references

1 reference

5

1 reference

25 December 2017

Stephen P. Fortmann

4

object named as

Stephen P Fortmann

1 reference

25 December 2017

author name string

Rex L Jamison

1

1 reference

25 December 2017

Pamela Hartigan

2

1 reference

25 December 2017

J Michael Gaziano

3

1 reference

25 December 2017

Jeffrey A Haroldson

6

1 reference

25 December 2017

James Kaufman

7

1 reference

25 December 2017

Philip Lavori

8

1 reference

25 December 2017

Kilmer S McCully

9

1 reference

25 December 2017

Killian Robinson

10

1 reference

25 December 2017

publication date

1 January 2004

1 reference

25 December 2017

published in

Clinical Trials

1 reference

25 December 2017

volume

1

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

page(s)

451-460

1 reference

25 December 2017

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

The oxidant stress of hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

The pathogenesis of coronary artery disease. A possible role for methionine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

The natural history of vascular disease in homocystinuria and the effects of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Sample size calculation for complex clinical trials with survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Coordinating center follow-up in the Veterans Administration Cooperative Study of Coronary Artery Bypass Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

A controlled trial of inpatient and outpatient geriatric evaluation and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

The effect of different treatment regimens in reducing fasting and postmethionine-load homocysteine concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 μmol/L

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN038OA

10.1191/1740774504CN038OA

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017